Y-C Hwang1, S Woo Oh2, S-W Park3, C-Y Park3. 1. Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee University School of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea. 2. Department of Family Medicine, Center for Obesity, Nutrition and Metabolism, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Republic of Korea. 3. Division of Endocrinology and Metabolism, Department of Internal Medicine, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Republic of Korea.
Abstract
BACKGROUND:C1q/TNF-Related Protein (CTRP) family members are novel adipokines that have anti-inflammatory, immunomodulatory, glucose-regulating and vascular effects. However, the metabolic effects of CTRP9 remain unclear in humans. OBJECTIVES: The aims of this study were to investigate whether serum CTRP9 concentrations are associated with glucose tolerance, metabolic parameters and abdominal fat accumulation. In addition, the authors investigated whether the aforementioned effects of CTRP9 are independent of serum adiponectin levels. METHODS: A total of 221 subjects (140 men and 81 women), 25-72 years of age (mean age 46.0 years), were randomly selected from two different study populations. The normal glucose tolerancegroup (n=120) was selected from one study population and the prediabetes/type 2 diabetes group (n=101) was selected from the other study population. Serum CTRP9, total adiponectin concentrations and abdominal fat via computed tomography scan were measured in all subjects. RESULTS: Subjects in the lower serum CTRP9 tertile were older, had metabolically unhealthy profiles and had lower serum total adiponectin levels when compared with subjects in the middle or upper serum CTRP9 tertiles. In addition, serum CTRP9 concentration were inversely correlated with age, blood pressure, fasting glucose, homeostasis model assessment for insulin resistance, total cholesterol, triglyceride and low-density lipoprotein cholesterol levels (all P<0.01) and positively correlated with serum total adiponectin levels (P=0.03). In terms of abdominal fat accumulation, serum CTRP9 concentrations were inversely correlated with visceral fat amount (P<0.01), but no correlation was observed with subcutaneous fat amount. Finally, serum CTRP9 was inversely associated with the presence of metabolic syndrome, independent of age, sex, body mass index, smoking status, total cholesterol, visceral fat and serum total adiponectin concentrations (odds ratio per 1 s.d. 0.47; 95% confidence interval 0.32-0.70; P<0.01). CONCLUSIONS:Serum CTRP9 concentrations were positively associated with favorable glucose or metabolic phenotypes and absence of metabolic syndrome, independent of serum total adiponectin concentrations.
RCT Entities:
BACKGROUND: C1q/TNF-Related Protein (CTRP) family members are novel adipokines that have anti-inflammatory, immunomodulatory, glucose-regulating and vascular effects. However, the metabolic effects of CTRP9 remain unclear in humans. OBJECTIVES: The aims of this study were to investigate whether serum CTRP9 concentrations are associated with glucose tolerance, metabolic parameters and abdominal fat accumulation. In addition, the authors investigated whether the aforementioned effects of CTRP9 are independent of serum adiponectin levels. METHODS: A total of 221 subjects (140 men and 81 women), 25-72 years of age (mean age 46.0 years), were randomly selected from two different study populations. The normal glucose tolerance group (n=120) was selected from one study population and the prediabetes/type 2 diabetes group (n=101) was selected from the other study population. Serum CTRP9, total adiponectin concentrations and abdominal fat via computed tomography scan were measured in all subjects. RESULTS: Subjects in the lower serum CTRP9 tertile were older, had metabolically unhealthy profiles and had lower serum total adiponectin levels when compared with subjects in the middle or upper serum CTRP9 tertiles. In addition, serum CTRP9 concentration were inversely correlated with age, blood pressure, fasting glucose, homeostasis model assessment for insulin resistance, total cholesterol, triglyceride and low-density lipoprotein cholesterol levels (all P<0.01) and positively correlated with serum total adiponectin levels (P=0.03). In terms of abdominal fat accumulation, serum CTRP9 concentrations were inversely correlated with visceral fat amount (P<0.01), but no correlation was observed with subcutaneous fat amount. Finally, serum CTRP9 was inversely associated with the presence of metabolic syndrome, independent of age, sex, body mass index, smoking status, total cholesterol, visceral fat and serum total adiponectin concentrations (odds ratio per 1 s.d. 0.47; 95% confidence interval 0.32-0.70; P<0.01). CONCLUSIONS: Serum CTRP9 concentrations were positively associated with favorable glucose or metabolic phenotypes and absence of metabolic syndrome, independent of serum total adiponectin concentrations.
Authors: Johanna Weigert; Markus Neumeier; Andreas Schäffler; Martin Fleck; Jürgen Schölmerich; Christian Schütz; Christa Buechler Journal: FEBS Lett Date: 2005-09-28 Impact factor: 4.124
Authors: Andrea Kopp; Margarita Bala; Johanna Weigert; Christa Büchler; Markus Neumeier; Charalampos Aslanidis; Jürgen Schölmerich; Andreas Schäffler Journal: Cytokine Date: 2009-12-01 Impact factor: 3.861
Authors: G William Wong; Sarah A Krawczyk; Claire Kitidis-Mitrokostas; Guangtao Ge; Eric Spooner; Christopher Hug; Ruth Gimeno; Harvey F Lodish Journal: FASEB J Date: 2008-09-11 Impact factor: 5.191
Authors: W J Kim; C Y Park; S E Park; E J Rhee; W Y Lee; K W Oh; S W Park; S W Kim; H S Park; Y J Kim; S J Song; H Y Ahn Journal: Diabet Med Date: 2012-09 Impact factor: 4.359
Authors: Scott A Lear; Karin H Humphries; Simi Kohli; Arun Chockalingam; Jiri J Frohlich; C Laird Birmingham Journal: Am J Clin Nutr Date: 2007-08 Impact factor: 7.045
Authors: Risa M Wolf; Kimberley E Steele; Leigh A Peterson; Xiange Zeng; Andrew E Jaffe; Michael A Schweitzer; Thomas H Magnuson; G William Wong Journal: J Clin Endocrinol Metab Date: 2016-03-16 Impact factor: 5.958
Authors: Michal Kasher Meron; Shuo Xu; Marshall J Glesby; Qibin Qi; David B Hanna; Kathryn Anastos; Robert C Kaplan; Jorge R Kizer Journal: AIDS Res Hum Retroviruses Date: 2019-09-03 Impact factor: 2.205
Authors: J T Schwartze; K Landgraf; U Spielau; D Rockstroh; D Löffler; J Kratzsch; W Kiess; A Körner Journal: Int J Obes (Lond) Date: 2016-12-05 Impact factor: 5.095
Authors: Colleen M Dewey; Kathryn M Spitler; Jessica M Ponce; Duane D Hall; Chad E Grueter Journal: J Am Heart Assoc Date: 2016-05-31 Impact factor: 5.501